- pulmonary
- Pulmonary vascular resistance, cardiac output. (clinicaltrials.gov)
- Subjects: About 15 patients with secondary pulmonary hypertension due to IPF or pulmonary fibrosis associated with collagen vascular diseases. (clinicaltrials.gov)
- Change in Hemodynamic Parameter (Pulmonary Vascular Resistance Index) From Baseline to Week 24. (clinicaltrials.gov)
- Cardiopulmonary hemodynamic measurements included the following: pulmonary vascular resistance index (PVRI). (clinicaltrials.gov)